Insider transactions
Published | Stock ▲ | Transactionratings | Value | Name | Relevance |
---|---|---|---|---|---|
2022-10-28 | Rubean AG | buy | €1,830.0 |
M2 Venture GmbH
in enger Beziehung |
|
2022-10-24 | Rubean AG | buy | €9,450.0 |
BMK Holding GmbH
in enger Beziehung |
|
2023-11-07 | Rubean AG | buy | €1,095.0 |
Mittnik, Prof. Dr. Stefan
Aufsichtsrat |
|
2023-11-06 | Rubean AG | hold | €299,600 |
BMK Holding GmbH
in enger Beziehung |
|
2023-11-06 | Rubean AG | buy | €14,572 |
BMK Holding GmbH
in enger Beziehung |
|
2023-11-06 | Rubean AG | buy | €2,688.0 |
BMK Holding GmbH
in enger Beziehung |
|
2023-11-06 | Rubean AG | buy | €2,620.0 |
BMK Holding GmbH
in enger Beziehung |
|
2020-10-30 | Rubean AG | buy | €10,000.0 |
von Borch, Petra
in enger Beziehung |
|
2020-10-30 | Rubean AG | buy | €130,000 |
M2 Venture GmbH
in enger Beziehung |
|
2023-11-02 | Rubean AG | buy | €1,270.0 |
Mittnik, Prof. Dr. Stefan
Aufsichtsrat |
|
2023-10-27 | Rubean AG | buy | €10,179 |
BMK Holding GmbH
in enger Beziehung |
|
2023-10-26 | Rubean AG | buy | €2,646.0 |
Pielage, Jochen
Vorstand |
|
2021-12-28 | Rubean AG | buy | €1,180.0 |
BMK Holding GmbH
in enger Beziehung |
|
2023-10-18 | Rubean AG | hold | €52,500 |
von Borch, Dr. Peter
Aufsichtsrat |
|
2024-03-25 | Rubean AG | buy | €74,995 |
von Borch, Dr. Peter
Aufsichtsrat |
|
2022-09-08 | Rubean AG | buy | €2,440.0 |
M2 Venture GmbH
in enger Beziehung |
|
2022-06-24 | Rubean AG | buy | €665.00 |
M2 Venture GmbH
in enger Beziehung |
|
2024-04-29 | Rubean AG | buy | €8,913.0 |
Mittnik, Prof. Dr. Stefan
Aufsichtsrat |
|
2022-07-29 | Rubean AG | buy | €3,675.0 |
BMK Holding GmbH
in enger Beziehung |
|
2022-09-05 | Rubean AG | buy | €1,907.0 |
M2 Venture GmbH
in enger Beziehung |
|
2022-07-29 | Rubean AG | buy | €1,460.0 |
BMK Holding GmbH
in enger Beziehung |
|
2022-08-24 | Rubean AG | buy | €1,812.0 |
BMK Holding GmbH
in enger Beziehung |
|
2023-10-05 | Schott Pharma AG & Co. Kgaa | buy | €94,743 |
Reisse, Andreas
Vorstand |
|
2023-10-05 | Schott Pharma AG & Co. Kgaa | buy | €47,385 |
Erkens, Ann-Kristin
Aufsichtsrat |
|
2024-03-04 | Schott Pharma AG & Co. Kgaa | sell | €80,000 |
Schulte, Dr. Jens
Aufsichtsrat |